Private Capital Group’s Core Laboratories CLB Stock Holding History

Private Capital Group’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-565	Closed	-$21K	–	1997
2019 Q4	$21K	Buy	565 +9	+2%	+$404	﹤0.01%	1079
2019 Q3	$26K	Buy	556 +69	+14%	+$3.21K	﹤0.01%	1075
2019 Q2	$61K	Sell	487 -44	-8%	-$2.58K	0.01%	574
2019 Q1	$37K	Buy	531 +1	+0.2%	+$67	0.01%	913
2018 Q4	$32K	Buy	530 +15	+3%	+$1.29K	0.01%	871
2018 Q3	$59K	Buy	515 +28	+6%	+$3.16K	0.01%	634
2018 Q2	$61K	Sell	487 -19	-4%	-$2.31K	0.01%	610
2018 Q1	$55K	Sell	506 -1	-0.2%	-$111	0.01%	633
2017 Q4	$56K	Buy	+507	New	+$50.6K	0.01%	647

Other funds holding CLB

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Private Capital Group's CLB Position: Q1 2020 in Review

Private Capital Group sold out of Core Laboratories (CLB) in Q1 2020, closing a stake of 565 shares — an estimated $21K sold.

Private Capital Group first reported a position in CLB in Q4 2017 and held it in 9 quarters. The position peaked at $61K in Q2 2019. 207 funds tracked by Wall St. Rank hold CLB as of Q1 2020.

Private Capital Group reported no remaining Core Laboratories position as of Q1 2020 after selling out during the quarter.
Private Capital Group sold 565 Core Laboratories shares in Q1 2020, an estimated $21K.
Private Capital Group first reported a position in Core Laboratories in Q4 2017 and held it in 9 quarters.
Private Capital Group's Core Laboratories position peaked at $61K in Q2 2019.
207 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2020.

Based on Private Capital Group's 13F filing for Q1 2020, filed 7 May 2020.